Investigating the Clinical Trial Journey and Engagement of Neuroendocrine Tumor Patients
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Number of neuroendocrine tumor patients who remain in clinical trial until completion
研究概览
简要总结
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is at least 18 years of age
- •Diagnosis of neuroendocrine tumor
- •Ability to understand and the willingness to sign a written informed consent document
排除标准
- •Enrolled in another research study
- •Patients with psychiatric illness/social situations that would limit compliance with study requirements
- •Pregnant or lactating woman
结局指标
主要结局
Number of neuroendocrine tumor patients who remain in clinical trial until completion
时间窗: 12 months
Rate of patients who decide to join in a neuroendocrine tumor clinical research
时间窗: 3 months
次要结局
未报告次要终点